NewsMarkets

Business

Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO

The gene therapy developer priced its initial public offering at the top of its range, raising $446.3 million.

2 publishers · 3 articles · first seen 24 Sept 2026 · updated 2h ago

How it unfolded

Every source in the order it published.

  1. Bloomberg MarketsAdarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
  2. QuartzADARx Pharmaceuticals raised $446 million in a biotech IPO backed by AbbVie
  3. QuartzADARx Pharmaceuticals sammelte 446 Millionen Dollar in einem Biotech-Börsengang, unterstützt von AbbVie.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO Bloomberg Markets ·
  2. ADARx Pharmaceuticals raised $446 million in a biotech IPO backed by AbbVie Quartz
  3. ADARx Pharmaceuticals sammelte 446 Millionen Dollar in einem Biotech-Börsengang, unterstützt von AbbVie. Quartz

In this story

  • Adarx Pharmaceuticals Inc.